No CrossRef data available.
Article contents
Interim Relief in Case of Inclusion of a Substance on the REACH Candidate List
Published online by Cambridge University Press: 20 January 2017
Abstract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
The manufacturer of a substance that is used safely and, in more than 99.9% of cases, used as an intermediate (and thereforeis exempted from the authorisation procedure) is deemed to have no legal grounds for claiming the suspension of the inclusion of that substance in the Candidate List for lack of urgency. Its mere inclusion should not automatically result in any significant damages to the manufacturer, neither should the Candidate List serve as a regulatory blacklist (official headnote).
- Type
- Case Notes
- Information
- Copyright
- Copyright © Cambridge University Press 2010
References
** Editorial Hint: Article 2(8) and 59 of Regulation 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), last amended by Regulation 552/2009, OJ L – 396, of 30.12.1996, pp. 1–849.
1 From the decision, it seems that acrylamide is used as isolated intermediate.
2 Candidate List available on the Internet at <http://echa.europa.eu/chem_data/authorisation_process/candidate_list_table_en.asp>.
4 “Suspend the operation of the contested decision pursuant to Article 105(2) of the Rules of Procedure of the Court, pending the ruling on the application for interim measures; in any event, suspend the operation of the contested decision with effect from the date on which it was adopted; grant any other interim measures as appropriate.”
5 There are also exemptions available from the authorisation requirement.
You have
Access